1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
Intracranial Giant Cell Reparative Granuloma Arising from the Temporal Lobe Area: MR Findings
=============================================================================================

* T. Lucien Mohammed
* David P. Brummett
* Francis J. Hahn
* Poonam Sharma

## Abstract

Summary: We present an unusual case of a giant cell reparative granuloma arising from the left temporal lobe area of a 38-year-old man and provide clinical and MR findings. Current diagnosis and treatment options are also discussed.

Giant cell reparative granulomas (GCRG) are benign, reparative, metabolic lesions that may exhibit local aggression and result in extensive tissue destruction in advanced cases (1). Although this relatively uncommon entity has been described most frequently involving the mandible and maxilla, it can also be found in the orbit (2), ethmoid sinus (3), and cranial vault (4). We present a case of GCRG of the temporal bone with associated MR findings.

## Case Report

A 38-year-old man was admitted to our medical center with a 2-year history of progressive fullness in his left ear, hearing loss, foul-smelling rhinorrhea, and dull, bilateral headaches. He denied any visual disturbances, tinnitus, nausea, or vomiting. The patient had a decreased ability to smell. Cranial nerves II–XII were grossly intact. No motor or sensory defects were demonstrated. The remainder of the neurologic tests and the general examination were normal.

A complete skull series was normal. Contrast-enhanced MR imaging of the brain revealed a 5.4 × 4 × 4-cm extraaxial mass in the left temporal fossa. The mass was isointense on T1-weighted images, hyperintense on T2-weighted images, and appeared well encapsulated, multilobular, and septated and showed capsular enhancement (Fig 1). There was no associated edema, but there was significant mass effect on the adjacent brain parenchyma. On the basis of radiologic findings, the preoperative diagnosis was giant cell tumor.

![fig 1.](http://www.ajnr.org/http://ajnr-stage2.stage.highwire.org/content/ajnr/22/5/873/F1.medium.gif)

[fig 1.](http://www.ajnr.org/content/22/5/873/F1)

fig 1. 
*A,* Axial T1-weighted MR image 9400/19/2 [TR/TE/excitations]). An isointense septated extraaxial mass in the left temporal fossa. 

*B,* Axial postcontrast T1-weighted MR image (650/11/2). Well-encapsulated mass with contrast enhancement of the capsule and septations.

*C,* Coronal postcontrast T1-weighted MR image (650/11/2). Extraaxial mass effect on the adjacent brain parenchyma is seen.

*D,* Axial T2-weighted MR image (3500/102/2). The mass is hyperintense on the T2-weighted image without associated edema

A left frontotemporal craniotomy yielded a 3 × 3-cm tumor that was beige, tough in consistency, and extradural in location and appeared to originate in the temporal bone. It was firmly attached to the overlying dura and was in one location. It extended through the squamosal portion of the temporal bone, invaded the petrous bone medially, the floor of the temporal fossa inferiorly, and the superior aspect of the mastoid laterally. The lesion was separated from the dura by a blunt and sharp dissection. It was completely resected along with a margin of grossly uninvolved bone.

On cut section, the specimen was composed predominantly of firm, beige tissue. Histologically, the tumor specimen consisted of giant cells and similar but mononuclear stromal cells, consistent with a diagnosis of GCRG (Fig 2).

![fig 2.](http://www.ajnr.org/http://ajnr-stage2.stage.highwire.org/content/ajnr/22/5/873/F2.medium.gif)

[fig 2.](http://www.ajnr.org/content/22/5/873/F2)

fig 2. 
*A,* Low-power microscopic section of the tumor shows randomly distributed multinucleated giant cells in spindle cell stroma (hematoxylin and eosin staining, magnification ×100). 

*B,* High-power microscopic section with numerous multinucleated giant cells (hematoxylin and eosin staining, magnification ×400)

A postoperative CT scan confirmed gross total tumor resection and the patient showed no neurologic deficit at discharge. There was no clinical or CT evidence of tumor recurrence 12 months after surgery (Fig 3).

![fig 3.](http://www.ajnr.org/http://ajnr-stage2.stage.highwire.org/content/ajnr/22/5/873/F3.medium.gif)

[fig 3.](http://www.ajnr.org/content/22/5/873/F3)

fig 3. 
A 12-month posttherapy CT scan with bone windows (3000/650) shows postoperative changes at the left temporal bone without evidence of tumor recurrence

## Discussion

In 1953, Jaffe (5) first described GCRG as benign lesions affecting the mandible and maxilla that were histologically distinct from true giant cell tumors of the bone (1). Originally, the pathogenesis of GCRG was thought to be a hyperplastic reparative reaction to interosseous hemorrhage induced by trauma (6); however, a definite history of trauma has not been verified in cases of GCRG. Other theories on the pathogenesis of GCRG, including infection and developmental causes, have been proposed, but no single theory has gained wide acceptance (6).

Although the most commonly reported radiographic finding is bony destruction with or without a soft tissue mass, GCRG do not have a distinguishing appearance and may mimic other expansile osseous lesions (7–9). Plain film characteristics of cranial GCRG are indistinguishable from other radiolucent skull lesions (10). On CT scans, irregular osseous destruction, calcifications, and contrast enhancement can be seen (8). CT alone, however, is insufficient to differentiate GCRG from other diagnostic possibilities. MR findings of GCRG include low T1 signal, high T2 signal with hypointense septations and variable contrast enhancement (8, 11).

Differential diagnoses of our lesion included giant cell tumors, GCRG, and “brown tumors” of hyperthyroidism. Other less likely osseous lesions with a giant cell component that were considered included aneurysmal bone cysts, nonossifying fibromas, fibrous dysplasias, chondroblastomas, and osteosarcomas (12–14). Giant cell tumors of the bone are hardest to distinguish from GCRG.

Owing to a lack of distinguishing radiologic features of GCRG, biopsy specimens are necessary to make an accurate diagnosis (8). Histologically, they are generally considered benign, although some do exhibit very aggressive behavior (10). These tumors consist of mononuclear, spindle-shaped, stromal cells along with multinucleated giant cells (8, 15). In GCRG, the giant cells tend to cluster and there is abundant new bone formation. In true giant cell tumors, the giant cells are more uniformly distributed, there is no new bone formation, and the mononuclear cells are round or oval. Unfortunately, no current consensus exists regarding the potential for aggressive behavior in a given case of GCRG (14).

The importance of distinguishing GCRG from giant cell tumor lies in the difference in prognosis, with giant cell tumors having a higher incidence of recurrence, metastasis, and malignant transformation (6). Regarding giant cell tumors, cerebral invasion, local recurrence, and late malignant transformation with lung metastatsis have all been reported (9, 10). Reed et al (14) documented a 6% rate of malignant transformation in giant cell tumors of long bones following irradiation and occurring at a mean interval of 13 years. The most common malignant sequelae encountered were fibrosarcoma, osteosarcoma, and malignant fibrous histiocytoma (10). Conversely, GCRG have lower rates of recurrence, ranging from 10% to 15% (6). To date, no documented metastatic transformation has occurred with GCRG (6)

Optimal management of GCRG is complete surgical excision (12, 16). Owing to their location, however, skull base tumors often do not lend themselves to complete excision. Fortunately, long-term remission has been reported with radical resection of accessible tumor when combined with radiotherapy (12, 16).

Regarding the elimination of residual GCRG, the role of adjuvant radiotherapy is controversial. Reports cited by Findlay et al (12) claim that GCRG are not radiosensitive and that radiation is accompanied by a significant risk of sarcomatous transformation. We concur with their review of giant cell reparative granulomas, which concluded that radiation should no be employed until all surgical alternative have been exhausted.

GCRG are uncommon benign lesions most commonly found in the mandible and maxilla. We present an unusual case involving the temporal bone of a 38-year-old man. The MR and pathology findings and treatment options for GCRG are discussed. Although the GCRG does commonly have certain MR characteristics, as discussed herein, the findings are not specific for this tumor and histologic analysis is required for diagnosis.

## Footnotes

*   1 Address reprint requests to Francis J. Hahn, MD, Department of Diagnostic Radiology, Division of Neuroradiology, University of Nebraska Medical Center, Omaha, NE 69198-1045.

## References

1.  Tallan EM, Olsen KD, McCaffrey TV, Unni KK, Lund BA. **Advanced giant cell granuloma: a twenty-year study.** Otolaryngol Head Neck Surg 1993;110:413-418
    
    

2.  Hoopes PC, Anderson RL, Blodi FC. **Giant cell (reparative) granuloma of the orbit.** Ophthalmology 1981;88:1361-1366
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=7322489&link_type=MED&atom=%2Fajnr%2F22%2F5%2F873.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=A1981MV76600037&link_type=ISI) 

3.  Wiatrak BJ, Gluckman JL, Fabian RL, Wesseler TA. **Giant cell reparative granuloma of the ethmoid sinus.** Otolaryngol Head Neck Surg 1987;97:504-509
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=3120130&link_type=MED&atom=%2Fajnr%2F22%2F5%2F873.atom) 

4.  Garza-Mercado R, Cavazos E, Hernandez-Batres F. **Giant cell reparative granuloma of the cranial vault: exceptional bone lesion.** Neurosurgery 1984;15:228-231
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1227/00006123-198408000-00012&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=6483139&link_type=MED&atom=%2Fajnr%2F22%2F5%2F873.atom) 

5.  Jaffe HL. **Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-osseous) dysplasia of the jawbones.** Oral Surg Oral Med Oral *Pathol* 1953;6:159-175
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1016/0030-4220(53)90151-0&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=13026160&link_type=MED&atom=%2Fajnr%2F22%2F5%2F873.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=A1953YB25900016&link_type=ISI) 

6.  Ung F, Li KK, Keith DA, McKenna MJ. **Giant cell reparative granuloma of the temporal bone: case report and review of the literature.** Otolaryngol Head Neck Surg 1998;118:525-529
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1016/S0194-5998(98)70212-8&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=9560106&link_type=MED&atom=%2Fajnr%2F22%2F5%2F873.atom) 

7.  Dahlin DC, Cupps RE, Johnson EW. **Giant cell tumor: a study of 195 cases.** Cancer 1970;25:1061-1070
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1002/1097-0142(197005)25:5<1061::AID-CNCR2820250509>3.0.CO;2-E&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=4910256&link_type=MED&atom=%2Fajnr%2F22%2F5%2F873.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=A1970G331300008&link_type=ISI) 

8.  Saleh EA, Taibah AK, Naguib M, et al. **Giant cell tumor of the lateral skull base: a case report.** Otolaryngol Head Neck Surg 1994;111:314-318
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1016/S0194-5998(94)70608-5&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=8084641&link_type=MED&atom=%2Fajnr%2F22%2F5%2F873.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=A1994PG59700022&link_type=ISI) 

9.  Wilbur AC, Choi KH, Tan WS, Jafar JJ, Spigos DG. **Giant cell tumor of the sphenoid bone mimicking a pituitary tumor.** AJNR Am J Neuroradiol 1986;7:361-362
    
    [FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6MzoiUERGIjtzOjExOiJqb3VybmFsQ29kZSI7czo0OiJham5yIjtzOjU6InJlc2lkIjtzOjc6IjcvMi8zNjEiO3M6NDoiYXRvbSI7czoxOToiL2FqbnIvMjIvNS84NzMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

10. Lee HJ, Lum C. **Giant cell tumor of the skull base.** Neuroradiology 1998;41:305-307
    
    

11. Halpin SFS, Britton JA, Uttley D. **Giant cell tumour of the skull base: MRI appearances–case report.** Neuroradiology 1991;34:526-527
    
    

12. Findlay JM, Chaisson D, Hudson AR, Chui M. **Giant cell tumor of the middle cranial fossa.** J Neurosurg 1987;66:924-928
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=3572521&link_type=MED&atom=%2Fajnr%2F22%2F5%2F873.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=A1987H454100019&link_type=ISI) 

13. Rhea JT, Weber AL. **Giant-cell granuloma of the sinuses.** Radiology 1983;147:135-137
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=6828718&link_type=MED&atom=%2Fajnr%2F22%2F5%2F873.atom) 

14. Reed L, Willison AL, Schochet SS, Voelker JL. **Giant cell tumor of the calvaria in a child.** J Neurosurg 1994;80:148-151
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.3171/jns.1994.80.1.0148&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=8271002&link_type=MED&atom=%2Fajnr%2F22%2F5%2F873.atom) 

15. Silvers AR, Sorn PM, Brandwein M, Chong JLM, Shah D. **The role of imaging in the diagnosis of giant cell tumor of the skull base.** AJNR Am J Neuroradiol 1996;17:1392-1395
    
    [Abstract](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiYWpuciI7czo1OiJyZXNpZCI7czo5OiIxNy83LzEzOTIiO3M6NDoiYXRvbSI7czoxOToiL2FqbnIvMjIvNS84NzMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

16. Wolfe JT, Scheithauer BW, Dahlin DC. **Giant cell tumor of the sphenoid bone.** J Neurosurg 1983;59:322-327
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=6864300&link_type=MED&atom=%2Fajnr%2F22%2F5%2F873.atom) 

*   Received August 14, 2000.


*   Copyright © American Society of Neuroradiology